Completed PHASE3 Interventional 2-arm
NCT01724008
The Efficacy of a Dentifrice in Providing Relief From Dentinal Hypersensitivity
A Clinical Study Investigating the Efficacy of a Dentifrice in Providing Immediate and Short Term Relief From Dentinal Hypersensitivity.
Sponsor: GlaxoSmithKline
Conditions
Dentine Hypersensitivity
Interventions
Sodium Monofluorophosphate Stannous Fluoride
Updated 2 times since 2017 Last updated: Mar 1, 2012
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A PHASE3 clinical study on Dentine Hypersensitivity, this trial is completed. The trial is conducted by GlaxoSmithKline and has accumulated 2 data snapshots since 2026. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
2 versions recorded-
Feb 2017 — Present [monthly]
Completed PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Completed PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- GlaxoSmithKline
Data source: GlaxoSmithKline
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.